A kind of anti-cancer pharmaceutical composition

A composition and drug technology, applied in the field of cancer drugs to achieve the effect of less toxic and side effects

Active Publication Date: 2021-05-28
INST OF ANIMAL SCI OF CHINESE ACAD OF AGRI SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its effects on other types of tumor cells, especially the selective inhibition of the survival and migration of liver cancer cells, have not been reported.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of anti-cancer pharmaceutical composition
  • A kind of anti-cancer pharmaceutical composition
  • A kind of anti-cancer pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1 Inhibiting the Survival Effect of Liver Cancer Cells

[0028] In order to detect the effect of phyllidine, lactoferrin, and phyllidine combined with lactoferrin on the survival of HepG2 cells, HepG2 cells were seeded in 96-well culture dishes (10 5 cells / well, 100 mL medium per well), after 24 hours of culture, 10 mg / L, 50 mg / L, 100 mg / L, 200 mg / L, 500 mg / L and 1 g / L Nantianine, 10 mg / L, 50mg / L, 100 mg / L, 200 mg / L, 500 mg / L and 1 g / L lactoferrin, and the combined group of Nantianine and lactoferrin ( 200 mg / L dose of nantiana combined with 100 mg / L dose of lactoferrin (mass ratio 2:1), 100 mg / L dose of nantiana combined with 100 mg / L dose of lactoferrin (mass ratio 1:1), 100 mg / L dose of nantiana combined with 200 mg / L dose of lactoferrin (mass ratio 1:2) (a total of 20 microliters for each group, 10 microliters for each drug in the combined administration group), for 24 hours , then discard the medium, add MTT (final concentration 5 g / L) to act for 4 hours,...

Embodiment 2

[0031] Example 2 Effect of Bambooline and Lactoferrin in Inhibiting HepG2 Tumor Growth in Nude Mice

[0032]The following groups were set up: no treatment control group, 25 mg / kg dose of nantiana, 50 mg / kg dose of lactoferrin, 25 mg / kg dose of nantiana combined with 50 mg / kg lactoferrin, 12.5 mg / kg dose Nantianning bamboo base combined with 25 mg / kg lactoferrin was used to detect the growth of HepG2 tumor in nude mice.

[0033] The experimental method is as follows: HepG2 cells were cultured on a large scale in 20 10cm culture dishes, and when the cell density reached about 80%, the cells were collected and injected subcutaneously into the right armpit of 20 BALb / C nude mice. After about three weeks, the tumor volume reached 90-110mm 3 . Mice (body weight 20 ± 1 g) were divided into 5 groups of 4 mice each. With 25mg / kg dose of nantiana, 50 mg / kg dose of lactoferrin, 25 mg / kg dose of nantiana combined with 50 mg / kg lactoferrin, 12.5 mg / kg dose of nantiana combined with 25mg...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of drugs for treating cancer, and in particular relates to an anti-cancer drug composition. The pharmaceutical composition includes culpentine and lactoferrin. These two compounds are natural compounds, which are derived from plant and animal source foods respectively. They have less toxic and side effects, and can effectively inhibit cancer with multiple targets and multiple mechanisms, especially the survival rate of liver cancer cells. or lactoferrin) can exert synergistic activity, and the drug combination containing the two components can be used for the clinical treatment and adjuvant treatment of cancer, especially liver cancer.

Description

technical field [0001] The invention belongs to the technical field of drugs for treating cancer, and in particular relates to an anti-cancer drug composition. Background technique [0002] Liver cancer is the sixth most common cancer and the fourth leading cause of cancer-related death worldwide, posing a serious threat to human health (Dubé C, et al. Amer. J. Gastro., 2017.). Liver cancer can be divided into primary and secondary two categories. Primary liver malignant tumors originate from the epithelial or mesenchymal tissues of the liver. Primary liver cancer includes hepatocellular carcinoma, cholangiocellular carcinoma and their mixed types. Among them, hepatocellular carcinoma is the most common liver malignant tumor, accounting for primary 45% of malignant liver cancer (El-Serag, et al. Gastroenterology, 2017.; Johnson et al., J. Clinical Oncology, 2013.). Secondary or metastatic liver cancer refers to the invasion of the liver by malignant tumors originating from...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/40A61K31/4375A61P35/00
CPCA61K31/4375A61K38/40A61P35/00A61K2300/00
Inventor 李慧颖郑楠王加启杨怀谷姚倩倩范琳琳张养东
Owner INST OF ANIMAL SCI OF CHINESE ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap